How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/nonradiographic-axial-spondyloarthritis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-11 · How we verify

Nonradiographic axial spondyloarthritis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nonradiographic axial spondyloarthritis (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Nonradiographic axial spondyloarthritis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Simponi	GOLIMUMAB	Centocor Ortho Biotech Inc	Tumor Necrosis Factor Blocker [EPC]	Tumor necrosis factor	2009-01-01
Enbrel	etanercept	Immunex	Tumor Necrosis Factor Blocker [EPC]	Tumor necrosis factor	1998-01-01
Simponi	Simponi	Alvotech Swiss AG		Tumor necrosis factor
Enbrel	Enbrel	LG Life Sciences		Tumor necrosis factor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Alvotech Swiss AG · 1 drug in Nonradiographic axial spondyloarthritis
Centocor Ortho Biotech Inc · 1 drug in Nonradiographic axial spondyloarthritis
Immunex · 1 drug in Nonradiographic axial spondyloarthritis
LG Life Sciences · 1 drug in Nonradiographic axial spondyloarthritis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Nonradiographic axial spondyloarthritis:

Cite this brief

Drug Landscape (2026). Nonradiographic axial spondyloarthritis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/nonradiographic-axial-spondyloarthritis. Accessed 2026-06-11.

Nonradiographic axial spondyloarthritis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing